Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study

Sponsor
Kocaeli University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05810571
Collaborator
(none)
60
2
3
13.1
30
2.3

Study Details

Study Description

Brief Summary

patients who will undergo elective open nephrectomy will be divided into three groups; the control (PCA), the erector spina plane block, and the quadratus lumborum block. After standard anesthesia induction and monitorization then Bispectral index monitoring will be applied to all patients. Anesthesia will be maintained using sevoflurane in a mixture of oxygen and air. Continuous remifentanil infusion will be used for analgesia. Then patient's numeric rating scales and morphine pca consumptions will be recorded for one day.

Condition or Disease Intervention/Treatment Phase
  • Procedure: preoperative remifentanil consumption
  • Procedure: postopeartive controlled anlagesia with morphine
N/A

Detailed Description

patients who will undergo elective open nephrectomy will be divided into three groups; the control (PCA), the erector spina plane block and the quadratus lumborum block. After standard anesthesia induction and monitorization then Bispectral index monitoring will be applied to all patients. Anesthesia will be maintained using sevoflurane in a mixture of oxygen and air. Continious remifentanil infusion will be used for analgesia. Then patient's numeric rating scales and morphine pca consumptions will be recorded for one day.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
participant will not know which block applied, and the outcome assessor of the postoperative analgesia will not know
Primary Purpose:
Diagnostic
Official Title:
Comparison of Erector Spina and Quadratus Lumborum in Open Nephrectomy
Actual Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Jan 3, 2024
Anticipated Study Completion Date :
Apr 3, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: patient controlled analgesia

this group of patients received no block, received only postoperative patient-controlled analgesia with morphine

Procedure: preoperative remifentanil consumption
continuous remifentanil infusion will applied for peroperative analgesia

Procedure: postopeartive controlled anlagesia with morphine
postoperative morphine patient controlled analgesia will be applied for postoperative analgesia

Active Comparator: erector spina plane block

this group of patients received erector spina plane block preoperatively, received only postoperative patient-controlled analgesia with morphine

Procedure: preoperative remifentanil consumption
continuous remifentanil infusion will applied for peroperative analgesia

Procedure: postopeartive controlled anlagesia with morphine
postoperative morphine patient controlled analgesia will be applied for postoperative analgesia

Active Comparator: quadratus lumborum block

this group of patients received erector spina plane block preoperatively, received only postoperative patient-controlled analgesia with morphine

Procedure: preoperative remifentanil consumption
continuous remifentanil infusion will applied for peroperative analgesia

Procedure: postopeartive controlled anlagesia with morphine
postoperative morphine patient controlled analgesia will be applied for postoperative analgesia

Outcome Measures

Primary Outcome Measures

  1. postoperative morphine consumption [24 hour postoperatively]

    amount of postoperative morphine use of the patient's

Secondary Outcome Measures

  1. peroperative remifentanil consumptions [4 hour preoperatively]

    amount of remifentanil use of the patient's

  2. numeric rating scale [24 hour postoperatively]

    numeric rating scores of the patient's postoepartively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA 1-3

  • open nephrectomy elective patients

  • BMI<35

Exclusion Criteria:
  • ASA 4-5-6

  • Laparoscopic nephrectomy

  • infection at the block side

  • coagulation disorder

  • BMI>35

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kocaeli University School of Medicine Kocaeli Turkey 41900
2 Kocaeli University Medical Faculty Kocaeli Turkey

Sponsors and Collaborators

  • Kocaeli University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zehra Ipek ARSLAN, Professor, Kocaeli University
ClinicalTrials.gov Identifier:
NCT05810571
Other Study ID Numbers:
  • KAEK / 12bl.01
First Posted:
Apr 12, 2023
Last Update Posted:
Apr 12, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zehra Ipek ARSLAN, Professor, Kocaeli University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2023